Real-World Data from Nearly 230,000 Implants1

Boston Scientific conducted an in-depth analysis on 9,000 patients with Boston Scientific defibrillators powered by EnduraLife Battery Technology and remotely monitored by the LATITUDE™ NXT Patient Management System, which continuously estimates device longevity based on the device programming and observed performance parameters. This real-world data on U.S. patients implanted since 2008 shows longevity estimates of 9.7 to 15.2 years for high voltage transvenous devices.
  

STAY UP TO DATE

Sign up to receive periodic emails about device longevity and how it impacts
patients, payers and the healthcare system.

Sign Up Now
Top